相关实验视频
Updated: Jul 16, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
327
重新平衡聚胺水平以治疗斯奈德-罗宾逊综合征
1Lankenau Institute for Medical Research, Wynnewood, PA, USA.
EMBO molecular medicine
|September 15, 2023
概括
斯奈德-罗宾逊综合征 (SRS) 是男性罕见的X相关疾病,导致智力障碍和发育迟缓. 它是由精氨酸合成酶基因突变引起的,影响神经和骨系统.
科学领域:
- 遗传学 遗传学 是一个
- 生物化学 生物化学
- 神经学 神经学
背景情况:
- 斯奈德-罗宾逊综合征 (SRS) 是一种罕见的X相关的衰退性疾病.
- 首次描述于1969年,SRS在全球范围内影响不到100人.
- 这种情况主要影响神经和骨系统.
研究的目的:
- 为了总结斯奈德-罗宾逊综合征的关键特征.
- 突出SRS.的遗传基础和临床表现.
- 为了强调目前缺乏特定的治疗方法.
主要方法:
- 对已记录的SRS病例进行文献综述.
- 分析与SRS相关的遗传突变.
- 临床特征和患者数据的汇编.
主要成果:
- SRS是由精子合成酶 (SMS) 基因中的功能丧失突变引起的.
- 受影响的男性表现出智力障碍,发育迟缓,低血压和骨问题.
- 临床特征包括语音/视觉障碍,,和明显的面部特征.
结论:
- 斯奈德-罗宾逊综合征是一种具有显著神经和骨影响的衰弱性遗传疾病.
- 在SMS基因的突变是SRS.的主要原因.
- 目前的治疗重点是缓解症状,目前还没有治疗方法.
相关概念视频
Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
Mania and Antimanic Drugs: Overview
224
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
224
Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Psychosis and Antipsychotic Drugs: Overview
321
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
321

